Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys versus Pegasys + adefovir for HBeAg-positive chronic hepatitis B
ChiCTR-TRC-09000612Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Oct 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of interferon alfa and adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: HBeAg quantity and HBV DNA quantity. Started Oct 2009; status: completed.
02
Drugs
interferon alfaadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-09000612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000612.